Michael L. Sierra PhD

Michael Sierra is currently working on a Scientific Advisory Board at the Proto Axiom. He has completed his PhD. He is specialized in Biotechnology. Dr. Sierra is leading a team of scientists with expertise in pharmacology and data science to explore technologies such as imaging, minimally/non-invasive biomarkers, and artificial intelligence to advance precision medicine in dermatology. He has an insightful perspective of what’s on the horizon with these disruptive and transformative technologies with respect to helping patients predict, diagnose, understand, and monitor their diseases.

Recently, Dr. Sierra was a featured speaker at the 4th Annual Dermatology Summit, 3rd Annual Dermatology Innovation Forum, and 2017 Nordic Precision Medicine Forum. Dr. Sierra and his team at LEO Science & Tech Hub were finalists for the 2017 Xconomy Award – Newcomer of the Year. Prior to this position, Dr. Sierra held the positions of Director of Medicinal Chemistry, Director of Chemical Research, Director of External Discovery, and Executive Director of Translational Research at LEO Pharma (Denmark).

He received his BS in chemistry from Ohio Northern University, PhD in chemistry at Wayne State University (USA), and held a 2-year post-doctoral position at Ecole Polytechnique, Palaiseau, France.